X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (42) 42
humans (37) 37
hematology (31) 31
oncology (28) 28
male (15) 15
myelodysplastic syndromes (15) 15
adult (14) 14
female (14) 14
cancer (13) 13
middle aged (12) 12
acute myeloid-leukemia (11) 11
leukemia (10) 10
aged (9) 9
care and treatment (9) 9
hemic and lymphatic diseases (9) 9
research (9) 9
treatment outcome (9) 9
abridged index medicus (8) 8
article (8) 8
older patients (8) 8
open-label (8) 8
acute myeloid leukemia (7) 7
aged, 80 and over (7) 7
apoptosis (7) 7
myelodysplastic syndrome (7) 7
patients (7) 7
analysis (6) 6
azacitidine (6) 6
chronic myelomonocytic leukemia (6) 6
electronic books (6) 6
impact (6) 6
international working group (6) 6
quality-of-life (6) 6
risk (6) 6
stem-cell transplantation (6) 6
survival (6) 6
transplantation (6) 6
anemia (5) 5
chronic myeloid-leukemia (5) 5
diagnosis (5) 5
disease progression (5) 5
international economics (5) 5
mutation (5) 5
myelodysplastic syndromes - diagnosis (5) 5
prognosis (5) 5
protein kinase inhibitors - therapeutic use (5) 5
response criteria (5) 5
safety (5) 5
scoring system (5) 5
therapy (5) 5
biochemistry & molecular biology (4) 4
biomarkers (4) 4
cell biology (4) 4
cell cycle (4) 4
chronic myeloid leukemia (4) 4
clinical trials as topic (4) 4
conventional care regimens (4) 4
dose-response relationship, drug (4) 4
economic policy (4) 4
economics (4) 4
efficacy (4) 4
genetic aspects (4) 4
global governance (4) 4
group of eight (4) 4
health aspects (4) 4
international cooperation (4) 4
international economic relations (4) 4
leukemia, myeloid, acute - drug therapy (4) 4
management (4) 4
mds (4) 4
medicine & public health (4) 4
myelodysplastic syndromes - drug therapy (4) 4
myelofibrosis (4) 4
myeloid leukemia (4) 4
pharmacokinetics (4) 4
prognostic scoring system (4) 4
prospective studies (4) 4
stem cells (4) 4
trial (4) 4
allele burden (3) 3
aml (3) 3
animals (3) 3
antimetabolites, antineoplastic - administration & dosage (3) 3
antimetabolites, antineoplastic - therapeutic use (3) 3
antineoplastic agents - pharmacology (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
aufsatzsammlung (3) 3
azacitidine - therapeutic use (3) 3
blast crisis (3) 3
bone marrow (3) 3
business & economics (3) 3
cancer research (3) 3
cardiac & cardiovascular systems (3) 3
carfilzomib (3) 3
cells (3) 3
chemotherapy (3) 3
chronic neutrophilic leukemia (3) 3
clinical trials and observations (3) 3
computer science, interdisciplinary applications (3) 3
cytogenetics (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Trinity College (John W Graham) - Stacks (6) 6
Robarts - Stacks (5) 5
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
UofT at Scarborough - Stacks (3) 3
Trinity College (John W Graham) - G8 Room (2) 2
UofT at Mississauga - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Criminology - Stacks (1) 1
Faculty of Information - Stacks (1) 1
Gerstein Science - Stacks (1) 1
Robarts - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 07/2019, Volume 37, Issue 21, pp. 1785 - 1785
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2019
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 09/2019, Volume 19, pp. S77 - S79
Journal Article
CANCER DISCOVERY, ISSN 2159-8274, 07/2019, Volume 9, Issue 7, pp. 831 - 833
Understanding resistance to BCL2 inhibition is a critical scientifi c and clinical challenge. In this issue of Cancer Discovery, two laboratories use unbiased... 
ONCOLOGY | INHIBITION | BIM
Journal Article
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 486 - 496
Umbralisib (TGR-1202) is a novel next-generation inhibitor of phosphatidylinositol 3-kinase (PI3K) isoform p110δ (PI3Kδ), which is structurally distinct from... 
GAMMA | B-CELL | 3-KINASE P110-DELTA | COLITIS | ONCOLOGY | IDELALISIB | PATHWAY
Journal Article
Journal Article
Blood, ISSN 0006-4971, 02/2011, Volume 117, Issue 6, pp. 1775 - 1776
Journal Article
Blood, ISSN 0006-4971, 03/2018, Volume 131, Issue 13, pp. 1415 - 1424
Pevonedistat (TAK-924/MLN4924) is a novel inhibitor of NEDD8-activating enzyme (NAE) with single-agent activity in relapsed/refractory acute myeloid leukemia... 
CONVENTIONAL CARE REGIMENS | CANCER-CELLS | APOPTOSIS | OLDER PATIENTS | MLN4924 | IN-VIVO | RISK MYELODYSPLASTIC SYNDROME | ACUTE MYELOID-LEUKEMIA | OVARIAN-CANCER | HEMATOLOGY | PHASE-I | Clinical Trials and Observations
Journal Article
Leukemia, ISSN 0887-6924, 2019, Volume 33, Issue 7, pp. 1747 - 1758
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1317 - 1326
Journal Article